Jose María Martinez Perez
Operationeel Directeur bij Gadea Grupo Farmacéutico SL
Oorsprong van het eerstegraads netwerk van Jose María Martinez Perez
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Gadea Grupo Farmacéutico SL
 Gadea Grupo Farmacéutico SL Pharmaceuticals: MajorHealth Technology Gadea Grupo Farmacéutico SL is a pharmaceutical company. It is engaged in manufacturing general APIs, steroids, sex hormones, sterile filtration products, and others. The company was founded by Gerardo Gutierrez Fuentes in 1991 and is headquartered in Boecillo, Spain.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jose María Martinez Perez via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Albany Molecular Research (UK) Ltd.
 Albany Molecular Research (UK) Ltd. Pharmaceuticals: MajorHealth Technology Albany Molecular Research (UK) Ltd. manufacture of pharmaceutical preparations. The company is headquartered in Holywell, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Albany Molecular Research (Glasgow) Ltd.
 Albany Molecular Research (Glasgow) Ltd. Pharmaceuticals: MajorHealth Technology Albany Molecular Research (Glasgow) Ltd. is based in Glasgow, UK. Part of Curia Global, Inc., Albany Molecular Research (Glasgow) Ltd. is a British company that provides pharmaceutical development services. The company was founded in 1997. Albany Molecular Research (Glasgow was acquired by Curia Global, Inc. from Aptuit LLC on January 09, 2015 for $24 million. | Pharmaceuticals: Major | Director/Board Member | |
Curia Germany GmbH
 Curia Germany GmbH Pharmaceuticals: MajorHealth Technology Part of Curia Global, Inc., Curia Germany GmbH is a company that specializes in Active Pharmaceutical Ingredients & Intermediates. The company is based in Frankfurt, Germany. The company provides quality products, reliably and responsibly applying the world's most difficult chemical technologies. The company was founded in 2006 and the CEOs are Joachim Kaus and Thomas Randall. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 4 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Mariesa Beth Coppola | 4 |
- Beurs
- Insiders
- Jose María Martinez Perez
- Bedrijfsconnecties
